Cme (CME) Shares Outstanding (2009 - 2026)

Cme (CME) has 18 years of Shares Outstanding data on file, last reported at $361.8 million in Q1 2026.

• Shares Outstanding for Q1 2026 came in at $361.8 million, up 7792.45% year-over-year; the trailing twelve-month figure through Mar 2026 was $361.8 million (up 7792.45% YoY), and the FY2025 annual result was $4.6 million, up 152700.0% from the prior year.
• Shares Outstanding rose to $361.8 million in Q1 2026 per CME's latest filing, from $4.6 million in the prior quarter.
• Over five years, Shares Outstanding peaked at $361.8 million in Q1 2026 and troughed at $3000.0 in Q1 2023.
• A 5-year average of $254.2 million and a median of $358.9 million in 2022 frame the typical range for Shares Outstanding.
• The sharpest annual moves came in 2024 and 2025: Shares Outstanding plunged 100.0% in 2024, then surged 11988133.33% in 2025.
• A 5-year view of Shares Outstanding shows it stood at $4.6 million in 2022, then surged by 7736.63% to $359.2 million in 2023, then sank by 100.0% to $3000.0 in 2024, then soared by 152700.0% to $4.6 million in 2025, then soared by 7792.45% to $361.8 million in 2026.
• Business Quant data shows CME's Shares Outstanding at $361.8 million in Q1 2026, $4.6 million in Q4 2025, and $4.6 million in Q3 2025.